Recorded content from this conference can be viewed below.
View session one. This video consists of the following presentations:
Watch PresentationIntroductory remarks
Professor Laura JV Piddock, Scientific Director, GARDP - View Bio
Regulatory challenges and global access to new antibiotics
Dr Ramanan Laxminarayan, Director, CDDEP - View Bio
View session two. This video consists of the following presentations:
Watch PresentationDual fluorescent timer module for screening of anti-persister agents
Professor Ranjana Pathania, Professor Indian Institute of Technology Roorkee (IIT Roorkee) - View Bio
Discovery and optimization of β-sliding clamp (DnaN) inhibitors
Professor Dr Anna Hirsch, Head of department, Drug Design and Optimization (DDOP) Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - View Bio
New ways to identify novel antibacterial chemical entities - Identification of Novel Antibacterials Using Machine Learning Techniques
Mr Ed Siegwart, Director of Microbiology, Oppilotech Ltd - View Bio
Q&A
View session three. This video consists of the following presentations:
Watch PresentationWHO Priority pathogen list and WHO preclinical pipeline analysis
Dr Valeria Gigante, Team Lead, One Health Research Priority-setting and Synergy in AMR, WHO - View Bio
Overview of CARB-X pipeline
Dr Erin Duffy, Chief of Research & Development, CARB-X - View Bio
View session four. This video consists of the following presentations:
Watch PresentationPanellist
Dr Susan Hopkins - View Bio
Panellist
Dr Priscilla Rupali - View Bio
Panellist
Dr Subasree Srinivasan - View Bio
Panellist
Prof. Dr Evelina Tacconelli - View Bio
Day one closing remarks
Dr Christopher Longshaw, Senior Director, EU Scientific Affairs, Shionogi BV & BSAC Honorary Treasurer - View Bio
View session five. This video consists of the following presentations:
Watch PresentationIntroductory remarks
Dr Christopher Longshaw, EU Scientific Advisor, Shionogi & BSAC Honorary Treasurer - View Bio
Overview of clinical pipeline for antimicrobials - will it meet the future unmet need?
Professor Mical Paul, Head, Division of Infectious Diseases, Rambam Health Care Campus, Israel - View Bio
Emerging antibiotic market in the Indian subcontinent
Mr Anmol Aggarwal, Lead, R&D Strategy, Venus Medicine Research Centre, India - View Bio
Clinical development of non-traditional antibiotics
Dr Balganesh Tanjore Soundararajan, President, Gangagen Biotechnologies Pvt Ltd, Bangalore, India - View Bio
Q&A
View session six. This video consists of the following presentations:
Watch PresentationEvaluating the veterinarian role in one health approach at antimicrobial resistance perspectives, Jordan
Bazzi Randa, Faculty of Public Health, University of Debrecen - View Bio
The ESKAPE pathogens mobilome
João Botelho, Postdoctoral Researcher, Max Planck Institute for Evolutionary Biology - View Bio
Utilising health belief model to assess antimicrobial awareness of Western Australian parents: A qualitative study
Aaron Alejandro, PhD Candidate, Murdoch University Australia - View Bio
Nanobodies as inhibitors of the SOS-response: a new class of potential suppressors of antimicrobial resistance
Filippo Vascon, PhD student, Università degli Studi di Padova - View Bio
Phage mediated beta-lactamases and carbapenemases in multi-drug resistant Escherichia coli
Juliet Roshini Mohan Raj, Assistant Professor, Nitte University Centre for Science Education and Research - View Bio
Q&A
View session seven. This video consists of the following presentations:
Watch PresentationImpact of Covid 19 on Antimicrobial stewardship
Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
How has Indian AMR data changed post-Covid
Dr Kamini Walia, Program officer AMR Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research - View Bio
Impact of Covid-19 on treatment of fungal infections
Dr Arunaloke Chakrabarti, President of International Society for Human and Animal Mycology (ISHAM) - View Bio
Q&A
View session eight. This video consists of the following presentations:
Watch PresentationPanellist
Dr Anand Anandkumar, Dr Jean-Pierre Paccaud, Ms Jenny Hellmann - View Bio
Panellist
Dr Anand Anandkumar, Co-Founder & CEO of Bugworks - View Bio
Panellist
Dr Jean-Pierre Paccaud, Director, Business Development and Corporate Strategy Global Antibiotic R&D Partnership (GARDP) - View Bio
Panellist
Ms Jenny Hellmann, Assistant chief of Antibiotics and Infection control unit, Public Health Agency of Sweden - View Bio
Closing remarks
Professor Laura JV Piddock, Scientific Director, GARDP - View Bio
Click here to view the virtual poster gallery from the conference